Literature DB >> 36266719

Prognosis-Related Nutritional Score for Cancer Patients (PRNS): a clinical nutritional score derived from a retrospective cohort study.

Bingdong Zhang1,2,3, Yuerui Li4,5, Yongbing Chen6,7,8.   

Abstract

BACKGROUND: Nutritional assessment and quality of life (QOL) have become important indices for therapeutic efficacy in patients with malignancies. We aim to develop and validate an easy-to-use questionnaire with prognostic value to assess nutritional status in hospitalized cancer patients.
METHODS: A comprehensive survey focused on patient-generated subjective global assessment (PG-SGA) and 30-item European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30 Chinese version) was performed in a cohort of 22,776 patients derived from the INSCOC study. Among them, 1948 patients were followed for 3 years after admission. An observational, retrospective, cross-sectional cohort study was conducted in accordance with TRIPOD statement. Breiman's random forest model was applied to calculate variable importance (VIMP) for items in PG-SGA and EORTC QLQ-C30 (Chinese version) for nutritional recommendation. Cox regression model was employed to construct Prognosis-Related Nutritional Score for Cancer Patients (PRNS). Kaplan-Meier Survival curve, ROC and DCA were calculated to evaluate prognostic value of nutritional status categorized by PRNS, and compared with PG-SGA.
RESULTS: Nutritional status was classified into 4 levels by PRNS scores: well nourished (≤ 4.5 points), mild malnourished (5-7.5 points), moderate malnourished (8-14.5 points), and severe malnourished (≥ 15 points). Significant median overall survival differences were found among nutritional status groups stratified by the PRNS (all Ps < 0.05). Compared with PG-SGA, PRNS had better prognostic value for survival stratified by nutritional status. The external, internal validity, test-retest reliability and rater reliability were satisfactory.
CONCLUSIONS: We systematically developed and validated PRNS as a nutrition screening tool for cancer patients. Compared with PG-SGA, PRNS has better prognostic value and simpler operation. TRIAL REGISTRATION: Investigation on Nutrition Status and its Clinical Outcome of Common Cancers, ChiCTR1800020329. Registered 24 December 2018-Retrospectively registered, http://www.chictr.org.cn/showproj.aspx?proj=31813.
© 2022. The Author(s).

Entities:  

Keywords:  30-item European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30); Cancer; Investigation on Nutritional Status and its Clinical Outcomes of Common Cancers (INSCOC); Nutrition screening and assessment; Patient-generated subjective global assessment (PG-SGA); Prognostic value; Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD)

Mesh:

Year:  2022        PMID: 36266719      PMCID: PMC9583551          DOI: 10.1186/s12967-022-03696-x

Source DB:  PubMed          Journal:  J Transl Med        ISSN: 1479-5876            Impact factor:   8.440


  31 in total

1.  Prevalence of protein-energy malnutrition risk in European older adults in community, residential and hospital settings, according to 22 malnutrition screening tools validated for use in adults ≥65 years: A systematic review and meta-analysis.

Authors:  Susanne Leij-Halfwerk; Marije H Verwijs; Sofie van Houdt; Jos W Borkent; P R Guaitoli; Thomas Pelgrim; Martijn W Heymans; Lauren Power; Marjolein Visser; Clare A Corish; Marian A E de van der Schueren
Journal:  Maturitas       Date:  2019-05-18       Impact factor: 4.342

2.  Development and validation of a nutrition screening tool for hospitalized cancer patients.

Authors:  Ji-Yeon Kim; Gyung-Ah Wie; Yeong-Ah Cho; So-Young Kim; Soo-Min Kim; Kum-Hee Son; Sang-Jae Park; Byung-Ho Nam; Hyojee Joung
Journal:  Clin Nutr       Date:  2011-08-02       Impact factor: 7.324

3.  Nutritional Screening Tools Used and Validated for Cancer Patients: A Systematic Review.

Authors:  Nélia Pinheiro Mendes; Thalita Alves de Barros; Carla de Oliveira Barbosa Rosa; Sylvia do Carmo Castro Franceschini
Journal:  Nutr Cancer       Date:  2019-04-29       Impact factor: 2.900

Review 4.  Rethinking nutritional support of the cancer patient: the new field of nutritional oncology.

Authors:  F D Ottery
Journal:  Semin Oncol       Date:  1994-12       Impact factor: 4.929

5.  Cancer-Associated Malnutrition and CT-Defined Sarcopenia and Myosteatosis Are Endemic in Overweight and Obese Patients.

Authors:  Lisa Martin; Ioannis Gioulbasanis; Pierre Senesse; Vickie E Baracos
Journal:  JPEN J Parenter Enteral Nutr       Date:  2019-04-22       Impact factor: 4.016

6.  The abridged patient-generated subjective global assessment is a useful tool for early detection and characterization of cancer cachexia.

Authors:  Antonio L Vigano; Jonathan di Tomasso; Robert D Kilgour; Barbara Trutschnigg; Enriqueta Lucar; José A Morais; Manuel Borod
Journal:  J Acad Nutr Diet       Date:  2014-01-24       Impact factor: 4.910

Review 7.  Definition of standardized nutritional assessment and interventional pathways in oncology.

Authors:  F D Ottery
Journal:  Nutrition       Date:  1996-01       Impact factor: 4.008

Review 8.  The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis.

Authors:  Kaiyu Sun; Shuling Chen; Jianbo Xu; Guanghua Li; Yulong He
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-31       Impact factor: 4.553

Review 9.  Nutritional Risk Screening and Assessment.

Authors:  Emilie Reber; Filomena Gomes; Maria F Vasiloglou; Philipp Schuetz; Zeno Stanga
Journal:  J Clin Med       Date:  2019-07-20       Impact factor: 4.241

10.  Patient-Generated Subjective Global Assessment Short Form better predicts length of stay than Short Nutritional Assessment Questionnaire.

Authors:  Priya Dewansingh; Margreet Euwes; Wim P Krijnen; Jaap H Strijbos; Cees P van der Schans; Harriët Jager-Wittenaar
Journal:  Nutrition       Date:  2021-05-31       Impact factor: 4.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.